Phase I trial of oral etoposide in combination with celecoxib in patients with advanced malignancies.

被引：0
|
作者：
Luu, TH [1 ]
Twardowski, P [1 ]
Leong, L [1 ]
Lim, D [1 ]
Morgan, R [1 ]
McNamara, M [1 ]
Portnow, J [1 ]
Ruel, C [1 ]
Shibata, S [1 ]
Synold, T [1 ]
Doroshow, J [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：241S / 241S
页数：1
相关论文
共 50 条
  • [1] Phase I trial of oral cyclophosphamide in combination with celecoxib in patients with advanced malignancies.
    Twardowski, P
    Chow, W
    Koczywas, M
    Leong, L
    Lim, D
    Margolin, K
    Morgan, R
    Ruel, C
    Shibata, S
    Synold, T
    Doroshow, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 240S - 240S
  • [2] Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
    Hubbard, Joleen Marie
    Kim, George P.
    Bored, Mitesh J.
    Qin, Rui
    Lensing, Janet
    Wright, John Joseph
    Erlichman, Charles
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
    Hubbard, Joleen Marie
    Kim, George P.
    Borad, Mitesh J.
    Qin, Rui
    Lensing, Janet
    Wright, John Joseph
    Erlichman, Charles
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [4] Phase I trial of SNS-595 in patients with advanced malignancies.
    Advani, R
    Gordon, M
    Hurwitz, H
    Mendelson, D
    Wakelee, H
    Ebbinghaus, S
    Hoch, U
    Silverman, J
    Havrilla, N
    Adelman, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 159S - 159S
  • [5] A phase I trial of the mTOR inhibitor temsirolimus (TEM) in combination with capecitabine (CAP) in patients with advanced malignancies.
    Pishvaian, Michael J.
    Wang, Hongkun
    Hardesty, Rosemarie A.
    Deeken, John F.
    He, Aiwu Ruth
    Subramaniam, Deepa Suresh
    Zhuang, Tingting
    McCarthy, Damian L.
    Melville, Heather
    Albanese, Christopher
    Marshall, John
    Hwang, Jimmy J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Brequinar in combination with cisplatin in patients with advanced malignancies. A phase I study with pharmacokinetics
    Burris, A
    Raymond, E
    Awada, A
    Kuhn, J
    O'Rourke, J
    Brentzel, J
    Lynch, W
    King, SY
    Brown, T
    Von Hoff, D
    ANNALS OF ONCOLOGY, 1998, 9 : 125 - 125
  • [7] Phase I/II trial with 111In-pentetreotide in patients with advanced malignancies.
    Argiris, A
    Peccerillo, K
    Murren, JR
    Cornelius, E
    Modlin, IM
    GASTROENTEROLOGY, 2000, 118 (04) : A515 - A515
  • [8] A phase I and pharmacologic trial of weekly epothilone B in patients with advanced malignancies.
    Oza, A
    Zamek, RM
    Siu, L
    Locsin, SM
    Moore, M
    Chen, F
    Chen, TL
    Cohen, P
    Rothermel, J
    Rubin, E
    ANNALS OF ONCOLOGY, 2000, 11 : 133 - 133
  • [9] Phase I trial of SNS-595 in patients (pts) with advanced malignancies.
    Advani, R
    Gordon, M
    Hurwitz, H
    Mendelson, D
    Wakelee, H
    Ebbinghaus, S
    Hoch, U
    Silverman, J
    Havrilla, N
    Adelman, D
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9056S - 9056S
  • [10] Phase I study of trabectedin (T) in combination with docetaxel (D) in patients with advanced malignancies.
    Von Mehren, M.
    Buck, D.
    Temmer, E.
    Elsayed, Y. A.
    Cohen, R. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
12345